Globe Newswire

Bermuda, May 15, 2024 Key information relating to return of capital and dividend to be paid by Avance Gas Holding Ltd. for the first quarter 2024 is specified as per below. The distribution of return of capital will be made from the Company’s Contributed Surplus account which consists of previously paid in share premium transferred from the Company’s Share Premium account.

Return of capital: $0.99 Dividend amount: $1.16 Declared currency: USD Last day including... (continue reading...)

BERMUDA, May 15, 2024 – Avance Gas Holding Ltd (OSE: AGAS) (“Avance Gas” or the “Company”) today reports unaudited results for the first quarter 2024.

HIGHLIGHTS

• The average time charter equivalent (TCE) rate basis discharge-to-discharge was $60,900/day, compared to $76,200/day for the fourth quarter 2023.
• TCE/day on load-to-discharge basis was $78,800/day compared to $71,900/day for the fourth quarter 2023.... (continue reading...)

ABN AMRO Bank posts net profit of EUR 674 million in Q1 2024 Q1 - Key messages of the quarter

• Very strong result with a net profit of EUR 674 million, driven by net interest income, fee income and low cost of risk
• Business momentum remained good; our mortgage loan book grew by EUR 0.8 billion and our corporate loan book by EUR 0.3 billion. We were market leader in mortgages in Q1
• Continued strong net interest income as we continued to benefit from the current... (continue reading...)

LONDON, 15 May. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire.

GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information provider.

Disclaimer

The content and accuracy of all information distributed through Notified is wholly the responsibility of the originator. Notified accepts no liability for any losses arising from reliance by any person upon the content of any announcement.

If you... (continue reading...)

• More than half of all U.S. cervical cancer patients are underscreened1, which makes reducing barriers to sample collection and increasing access to screenings crucial to ultimately helping eliminate this deadly disease.
• Each year in the U.S., more than 13,000 patients are diagnosed with cervical cancer and approximately 4,000 die from this preventable disease, caused by HPV infection.1
• Roche’s human papillomavirus (HPV) self-collection solution will improve access to... (continue reading...)